0
We are pleased to announce the acquisition of HealthTech Bio Actives, S.L.U. (HTBA) as of 12 December 2019 by The Riverside Company.
The Riverside Company ("Riverside") is a global private equity firm that focuses on acquiring growing enterprises. Riverside partners with strong management teams and enhances its investments through acquisitions and organic growth. Riverside completes acquisitions smoothly thanks to its c. $10.0 billion in assets under management with more than 200 professionals worldwide.
As you know, HTBA's activities comprise active pharmaceutical ingredients, food and dietary supplement ingredients and animal health and nutrition ingredients. It is present in these market segments in over 70 countries and focuses, among other things, on polyphenols and Vitamin B12 derivatives.
With regards to HTBA, Riverside has previous experience with past investments in Europe and USA in the sector of specialty ingredients or extract manufacturers for the pharmaceutical, dietary supplements and Food & Beverage sectors. Since its founding in 1988, Riverside has invested in more than 120 healthcare companies ranking among the most active healthcare investors in the world and 160 specialty manufacturing companies with significant knowledge in F&B ingredients sector including pet food manufacturing (i.e. animal nutrition).
We at HTBA are delighted with Riverside as a partner since they will bring additional resources to accelerate growth. By this, we mean capacity expansion, investment in new product development and enhanced commercial presence.
We are convinced that the combination of the strong investment philosophy of Riverside together with the commercial and R&D skills of HTBA will translate in joint growth opportunities with our partners.
At HTBA we are excited with this new development and are looking forward to continuing our collaboration with you, just as we have done until now.
Thank you very much for your continued collaboration.
Alexandre Valls-Coma
CEO
December 12, 2019 - Ferrer Health Tech
